334 related articles for article (PubMed ID: 24104388)
1. Primary aldosteronism: a new insight into pathogenesis, diagnosis, and treatment in hypertensive patients.
Hyla-Klekot L; Kokot F
Pol Arch Med Wewn; 2013; 123(10):547-51. PubMed ID: 24104388
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Weiner ID
Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
[TBL] [Abstract][Full Text] [Related]
3. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
4. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy.
Riester A; Reincke M
Eur J Endocrinol; 2015 Jan; 172(1):R23-30. PubMed ID: 25163723
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of primary aldosteronism.
Vilela LAP; Almeida MQ
Arch Endocrinol Metab; 2017; 61(3):305-312. PubMed ID: 28699986
[TBL] [Abstract][Full Text] [Related]
6. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
7. Primary aldosteronism: diagnostic and treatment strategies.
Mattsson C; Young WF
Nat Clin Pract Nephrol; 2006 Apr; 2(4):198-208; quiz, 1 p following 230. PubMed ID: 16932426
[TBL] [Abstract][Full Text] [Related]
8. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
9. Primary aldosteronism: diagnostic and therapeutic considerations.
Nishizaka MK; Calhoun DA
Curr Cardiol Rep; 2005 Nov; 7(6):412-7. PubMed ID: 16256009
[TBL] [Abstract][Full Text] [Related]
10. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperaldosteronism associated with hypertensive emergencies.
Labinson PT; White WB; Tendler BE; Mansoor GA
Am J Hypertens; 2006 Jun; 19(6):623-7. PubMed ID: 16783876
[TBL] [Abstract][Full Text] [Related]
12. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
[TBL] [Abstract][Full Text] [Related]
13. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
[TBL] [Abstract][Full Text] [Related]
14. [The difficulties in differential diagnosis of primary aldosteronism subtypes in women with strokes at a young age].
Bohdanowicz-Pawlak A; Szymczak J; Jakubowska J; Brona A
Endokrynol Pol; 2009; 60(6):492-6. PubMed ID: 20041369
[TBL] [Abstract][Full Text] [Related]
15. A possible association between primary aldosteronism and a lower beta-cell function.
Mosso LM; Carvajal CA; Maiz A; Ortiz EH; Castillo CR; Artigas RA; Fardella CE
J Hypertens; 2007 Oct; 25(10):2125-30. PubMed ID: 17885557
[TBL] [Abstract][Full Text] [Related]
16. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
Matsuda Y; Kawate H; Matsuzaki C; Sakamoto R; Shibue K; Ohnaka K; Anzai K; Nomura M; Takayanagi R
Endocr J; 2016; 63(3):249-55. PubMed ID: 26727302
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
Tezuka Y; Turcu AF
Endocr Pract; 2020 Dec; 26(12):1416-1424. PubMed ID: 33471733
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
Carey RM
Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
[TBL] [Abstract][Full Text] [Related]
19. Primary aldosteronism in hypertensive patients: clinical implications and target therapy.
Papanastasiou L; Markou A; Pappa T; Gouli A; Tsounas P; Fountoulakis S; Kounadi T; Tsiama V; Dasou A; Gryparis A; Samara C; Zografos G; Kaltsas G; Chrousos G; Piaditis G
Eur J Clin Invest; 2014 Aug; 44(8):697-706. PubMed ID: 24909545
[TBL] [Abstract][Full Text] [Related]
20. Primary Aldosteronism: Present and Future.
Funder JW
Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]